Statistics for Navigating Second-Line Therapy in Metastatic Renal Cell Carcinoma: a Comparative Analysis of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors: a Study of Turkish Oncology Group Kidney Cancer Consortium
Total visits
| views | |
|---|---|
| Navigating Second-Line Therapy in Metastatic Renal Cell Carcinoma: a Comparative Analysis of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors: a Study of Turkish Oncology Group Kidney Cancer Consortium | 3 |
Total visits per month
| views | |
|---|---|
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 3 |
| March 2026 | 0 |
Top country views
| views | |
|---|---|
| China | 3 |